Atomistry » Sodium » PDB 4fpa-4gfi » 4gaf
Atomistry »
  Sodium »
    PDB 4fpa-4gfi »
      4gaf »

Sodium in PDB 4gaf: Crystal Structure of Ebi-005, A Chimera of Human Il-1BETA and Il-1RA, Bound to Human Interleukin-1 Receptor Type 1

Protein crystallography data

The structure of Crystal Structure of Ebi-005, A Chimera of Human Il-1BETA and Il-1RA, Bound to Human Interleukin-1 Receptor Type 1, PDB code: 4gaf was solved by J.Hou, S.A.Townson, J.T.Kovalchin, A.Masci, O.Kiner, Y.Shu, B.King, C.Thomas, K.C.Garcia, E.S.Furfine, T.M.Barnes, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 41.86 / 2.15
Space group C 2 2 21
Cell size a, b, c (Å), α, β, γ (°) 60.350, 149.270, 126.170, 90.00, 90.00, 90.00
R / Rfree (%) 21.6 / 27.1

Sodium Binding Sites:

The binding sites of Sodium atom in the Crystal Structure of Ebi-005, A Chimera of Human Il-1BETA and Il-1RA, Bound to Human Interleukin-1 Receptor Type 1 (pdb code 4gaf). This binding sites where shown within 5.0 Angstroms radius around Sodium atom.
In total only one binding site of Sodium was determined in the Crystal Structure of Ebi-005, A Chimera of Human Il-1BETA and Il-1RA, Bound to Human Interleukin-1 Receptor Type 1, PDB code: 4gaf:

Sodium binding site 1 out of 1 in 4gaf

Go back to Sodium Binding Sites List in 4gaf
Sodium binding site 1 out of 1 in the Crystal Structure of Ebi-005, A Chimera of Human Il-1BETA and Il-1RA, Bound to Human Interleukin-1 Receptor Type 1


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 1 of Crystal Structure of Ebi-005, A Chimera of Human Il-1BETA and Il-1RA, Bound to Human Interleukin-1 Receptor Type 1 within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Na505

b:34.2
occ:1.00
O B:THR193 2.3 31.5 1.0
O B:HOH642 2.3 22.9 1.0
O B:HOH627 2.3 25.6 1.0
OG B:SER18 2.6 33.2 1.0
OG1 B:THR193 2.6 33.5 1.0
OE1 B:GLU21 2.6 31.3 1.0
C B:THR193 3.1 31.6 1.0
CB B:SER18 3.4 35.3 1.0
CD B:GLU21 3.4 29.1 1.0
OE2 B:GLU21 3.5 34.6 1.0
CB B:THR193 3.6 36.5 1.0
CA B:THR193 3.7 33.1 1.0
N B:THR193 3.7 33.9 1.0
O B:HOH674 3.9 27.7 1.0
N B:SER18 3.9 35.2 1.0
O B:HOH609 4.0 34.0 1.0
N B:ARG194 4.0 29.9 1.0
CA B:ARG194 4.2 29.8 1.0
NH1 B:ARG194 4.2 37.6 1.0
O B:HOH617 4.3 22.0 1.0
CA B:SER18 4.3 33.7 1.0
O B:HOH626 4.5 12.0 1.0
O B:HOH607 4.6 14.6 1.0
O B:HOH606 4.7 22.9 1.0
CG B:GLU21 4.8 29.3 1.0
CG2 B:THR193 5.0 33.5 1.0
C B:SER17 5.0 36.6 1.0
C B:ILE192 5.0 35.2 1.0
C B:ARG194 5.0 29.6 1.0

Reference:

J.Hou, S.A.Townson, J.T.Kovalchin, A.Masci, O.Kiner, Y.Shu, B.M.King, E.Schirmer, K.Golden, C.Thomas, K.C.Garcia, G.Zarbis-Papastoitsis, E.S.Furfine, T.M.Barnes. Design of A Superior Cytokine Antagonist For Topical Ophthalmic Use. Proc.Natl.Acad.Sci.Usa V. 110 3913 2013.
ISSN: ISSN 0027-8424
PubMed: 23431173
DOI: 10.1073/PNAS.1217996110
Page generated: Mon Oct 7 15:32:09 2024

Last articles

Mg in 7BGI
Mg in 7BLX
Mg in 7BLZ
Mg in 7BOD
Mg in 7BNR
Mg in 7BNK
Mg in 7BMC
Mg in 7BM9
Mg in 7BM8
Mg in 7BM6
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy